Management of Decongestion in Acute Heart Failure: Time for a new approach?
As the primary cause of hospitalization in acute heart failure (AHF) patients, congestion was responsible for a higher risk of mortality, rehospitalization, and renal dysfunction in AHF patients. Although loop diuretic was routinely used as the mainstay of AHF therapy, it is still ineffective to ob...
Main Author: | Miftah Pramudyo |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Heart Association
2023-05-01
|
Series: | Majalah Kardiologi Indonesia |
Subjects: | |
Online Access: | https://ijconline.id/index.php/ijc/article/view/1381 |
Similar Items
-
Timing of decongestion and its impact on acute heart failure prognosis
by: Aneta Kosiorek, et al.
Published: (2023-08-01) -
Tolvaptan add-on therapy and its effects on efficacy parameters and outcomes in patients hospitalized with heart failure
by: Tikal Kansara, MBBS, MD, et al.
Published: (2022-01-01) -
Possible Option for Treatment of Severe Congestive Heart Failure Under Mechanical Ventilation Using Tolvaptan via Nasogastric Tube: A Single-Center Analysis
by: Takeda Morihiko, et al.
Published: (2021-12-01) -
Tolvaptan add‐on therapy in patients with acute heart failure: A systematic review and meta‐analysis
by: Xiandu Luo, et al.
Published: (2020-06-01) -
Temporal trends of a vasopressin V2 receptor antagonist in heart failure using a nationwide database in Japan
by: Takashi Kuragaichi, et al.
Published: (2021-02-01)